Dupilumab facial redness: Positive effect of itraconazole

Fleur S A de Beer; Daphne S Bakker; Inge Haeck; Lieneke Ariens; Jorien van der Schaft; Marijke R van Dijk; Marjolein S de Bruin-Weller

doi:10.1016/j.jdcr.2019.07.020

Dupilumab facial redness: Positive effect of itraconazole

JAAD Case Rep. 2019 Oct 22;5(10):888-891. doi: 10.1016/j.jdcr.2019.07.020. eCollection 2019 Oct.

Authors

Fleur S A de Beer¹, Daphne S Bakker¹, Inge Haeck², Lieneke Ariens¹, Jorien van der Schaft¹, Marijke R van Dijk³, Marjolein S de Bruin-Weller¹

Affiliations

¹ Department of Allergology and Dermatology, University Medical Centre Utrecht, National Expertise Center for Eczema, Utrecht, The Netherlands.
² Department of Dermatology, Reinier de Graaf Gasthuis, Delft, The Netherlands.
³ Department of Pathology, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.

No abstract available

Keywords: ACD, allergic contact dermatitis; AD, atopic dermatitis; DFR, dupilumab facial redness; HND, head-neck dermatitis; IL, interleukin; Th2, T-helper type 2–mediated inflammatory response; atopic dermatitis; dupilumab; dupilumab facial redness; head-neck dermatitis.

Publication types

Case Reports